Pathological Conditions, Signs and Symptoms Commons^™

The Clinical Utility Of Concomitant Pten And Fas Deletion As An Early Indicator For Prostate Adenocarcinoma Subtypes That Lead To Extracapsular Metastasis, Brendan J. Coulter, Phillip Harries

Electronic Theses & Dissertations

The utility of genes PTEN and FAS as prognostic markers for the identification of early and/or aggressive prostatic adenocarcinomas is seemingly validated in the study results we obtained using fluorescence in-situ hybridization (FISH) of archived paraffin embedded surgical prostate core biopsy samples obtained from two CLIA and CAP licensed anatomical pathology labs (Bostwick Laboratories, Uniondale, NV and GoPath Laboratories, Buffalo Grove, IL). From early benign subsets of sample cases to aggressive extracapsular invasive tumors, the presence of random deletions evolves into clonal populations of co-deletion of both genes at question. We identify independent research that demonstrates the ability of these …